SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway

J Exp Clin Cancer Res. 2020 Jun 29;39(1):121. doi: 10.1186/s13046-020-01625-8.

Abstract

Background: Angiogenesis plays an important role in the progress of glioma. RNA-binding proteins (RBPs) and circular RNAs (circRNAs), dysregulated in various tumors, have been verified to mediate diverse biological behaviors including angiogenesis.

Methods: Quantitative real-time PCR (qRT-PCR) and western blot were performed to detect the expression of SRSF10, circ-ATXN1, miR-526b-3p, and MMP2/VEGFA. The potential function of SRSF10/circ-ATXN1/miR-526b-3p axis in glioma-associated endothelial cells (GECs) angiogenesis was further studied.

Results: SRSF10 and circ-ATXN1 were significantly upregulated in GECs compared with astrocyte-associated endothelial cells (AECs). Knockdown of SRSF10 or circ-ATXN1 significantly inhibited cell viability, migration and tube formation of GECs where knockdown of SRSF10 exerted its function by inhibiting the formation of circ-ATXN1. Moreover, the combined knockdown of SRSF10 and circ-ATXN1 significantly enhanced the inhibitory effects on cell viability, migration and tube formation of GECs, compared with knockdown of SRSF10 and circ-ATXN1, respectively. MiR-526b-3p was downregulated in GECs. Circ-ATXN1 functionally targeted miR-526b-3p in an RNA-induced silencing complex. Up-regulation of miR-526b-3p inhibited cell viability, migration and tube formation of GECs. Furthermore, miR-526b-3p affected the angiogenesis of GECs via negatively regulating the expression of MMP2/VEGFA.

Conclusion: SRSF10/circ-ATXN1/miR-526b-3p axis played a crucial role in regulating the angiogenesis of GECs. The above findings provided new targets for anti-angiogenic therapy in glioma.

Keywords: Angiogenesis; Circ-ATXN1; Glioma; Glioma associated endothelial cells; SRSF10; miR-526b-3p.

MeSH terms

  • Apoptosis
  • Ataxin-1 / genetics
  • Ataxin-1 / metabolism*
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Brain Neoplasms / blood supply*
  • Brain Neoplasms / genetics
  • Brain Neoplasms / metabolism
  • Brain Neoplasms / pathology
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism*
  • Cell Movement
  • Cell Proliferation
  • Gene Expression Regulation, Neoplastic
  • Glioma / blood supply*
  • Glioma / genetics
  • Glioma / metabolism
  • Glioma / pathology
  • Humans
  • Matrix Metalloproteinase 2 / genetics
  • Matrix Metalloproteinase 2 / metabolism*
  • MicroRNAs / genetics*
  • Neovascularization, Pathologic*
  • RNA, Circular / antagonists & inhibitors
  • RNA, Circular / genetics
  • RNA, Circular / metabolism*
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism*
  • Serine-Arginine Splicing Factors / genetics
  • Serine-Arginine Splicing Factors / metabolism*
  • Tumor Cells, Cultured

Substances

  • ATXN1 protein, human
  • Ataxin-1
  • Biomarkers, Tumor
  • Cell Cycle Proteins
  • MIRN526 microRNA, human
  • MicroRNAs
  • RNA, Circular
  • Repressor Proteins
  • SRSF10 protein, human
  • Serine-Arginine Splicing Factors
  • MMP2 protein, human
  • Matrix Metalloproteinase 2